ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
The Saturday Paper9 分钟
Voyage and return
The garden takes root in the memory as much as in the soil, and can bring solace to the traveller far from home.